MA44558B1 - Glucagon derivative, conjugate thereof, composition comprising it and therapeutic use thereof - Google Patents
Glucagon derivative, conjugate thereof, composition comprising it and therapeutic use thereofInfo
- Publication number
- MA44558B1 MA44558B1 MA44558A MA44558A MA44558B1 MA 44558 B1 MA44558 B1 MA 44558B1 MA 44558 A MA44558 A MA 44558A MA 44558 A MA44558 A MA 44558A MA 44558 B1 MA44558 B1 MA 44558B1
- Authority
- MA
- Morocco
- Prior art keywords
- conjugate
- composition
- therapeutic use
- glucagon derivative
- glucagon
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La présente invention concerne un dérivé du glucagon, un conjugué de celui-ci, une composition le comprenant et une utilisation de celui-ci. L'invention concerne plus particulièrement une utilisation thérapeutique pour le syndrome métabolique, l'hypoglycémie et l'hyperinsulinémie concomitante.The present invention relates to a derivative of glucagon, a conjugate thereof, a composition comprising it and a use thereof. The invention relates more particularly to a therapeutic use for metabolic syndrome, concomitant hypoglycemia and hyperinsulinemia.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20160081995 | 2016-06-29 | ||
PCT/KR2017/006922 WO2018004283A2 (en) | 2016-06-29 | 2017-06-29 | Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
MA44558A1 MA44558A1 (en) | 2020-02-28 |
MA44558B1 true MA44558B1 (en) | 2022-04-29 |
Family
ID=63963830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA44558A MA44558B1 (en) | 2016-06-29 | 2017-06-29 | Glucagon derivative, conjugate thereof, composition comprising it and therapeutic use thereof |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR108969A1 (en) |
MA (1) | MA44558B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115634285A (en) * | 2021-07-20 | 2023-01-24 | 派格生物医药(苏州)股份有限公司 | Application of polypeptide conjugate in preparation of medicines for treating diseases related to glycometabolism |
-
2017
- 2017-06-29 AR ARP170101804A patent/AR108969A1/en unknown
- 2017-06-29 MA MA44558A patent/MA44558B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR108969A1 (en) | 2018-10-17 |
MA44558A1 (en) | 2020-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018502742A1 (en) | Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof | |
MA49545B1 (en) | Glucagon derivative and composition comprising a long-acting conjugate thereof | |
CL2022000448A1 (en) | Autoinjector (divisional application no. 201903061) | |
CL2022000027A1 (en) | PCSK9 antagonist compounds. (Application divisional 202003257). | |
UY37278A (en) | ANTI-B7-H3 ANTIBODIES AND DRUG AND ANTIBODY CONJUGATES | |
MA43518A (en) | 3-AZABICYCLO [3.1.0] SUBSTITUTED HEXANES SERVING AS KETOHEXOKINASE INHIBITORS | |
MA39362A1 (en) | Stable compositions of uncomplexed iodine and methods of use | |
BR112017008666A2 (en) | anti-fgfr2 / 3 antibodies and methods of use | |
EA201690613A1 (en) | IMPROVED COMPOSITIONS BASED ON ADENOVIRUSES | |
EA201900562A1 (en) | BIS-OCTAGHYDROPHENANTHRENE CARBOXAMIDES AND THEIR PROTEIN CONJUGATES | |
EA201591805A1 (en) | OXABICICLO [2.2.2] ACIDS - MODULATORS GPR120 | |
EA202190708A1 (en) | EXPRESSION MODULATORS PNPLA3 | |
EA201692204A1 (en) | COMPOSITIONS AND METHODS OF MODULATING THE EXPRESSION OF COMPLEX B FACTOR | |
PH12019501018A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
EA201892119A1 (en) | DRUGS, OBTAINED BY COMBINING AGONIST FXR AND ARB | |
BR112015019587A2 (en) | combinations comprising maba compounds and corticosteroids | |
CL2016003023A1 (en) | "Compounds derived from (benzyl-piperazin-1-yl) (tetrahydrofuran-carbonyl or tetrahydropyran-carbonyl) substituted, rorg modulators; pharmaceutical composition comprising them; and its use in the treatment of multiple sclerosis and ankylosing spondylitis. ” pct | |
EP4293116A3 (en) | Stable liquid fibrinogen | |
EA201792262A1 (en) | PIROGLUTAMAT VORTIOKSETINA | |
EA201791716A1 (en) | PHARMACEUTICAL COMPOSITION | |
EA202191471A1 (en) | ANTI-INFLAMMATORY POLYPEPTIDES | |
SV2018005701A (en) | 1,3,4-TIADIAZOL COMPOUNDS AND THEIR USE IN CANCER TREATMENT | |
MA44558A1 (en) | Glucagon derivative, conjugate thereof, composition comprising it and therapeutic use thereof | |
CL2019003249A1 (en) | Improved protocol for the treatment of lupus nephritis. | |
MX2020003554A (en) | MODULATORS OF ENaC EXPRESSION. |